Empagliflozin/metformin - Boehringer Ingelheim/Eli Lilly and Company
At a glance
- Drug Originator Boehringer Ingelheim
- Drug Licenced by Cipla; Eli Lilly and Company; Lupin
- Drug Class Antihyperglycaemics; Benzhydryl compounds; Biguanides; Cyclic ethers; Glucosides; Small molecules
- Mechanism of Action AMP activated protein kinase stimulants; Gluconeogenesis inhibitors; Sodium-glucose transporter 2 inhibitors
- USA Patent Applicants BOEHRINGER INGELHEIM
- USA Patents 14
- NDAs 2
- International Patents 306
Table of Contents

Disclaimer